The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis

Jurgen Eckel; TANAKA Hideho; ISHII ShinichiLisen Liu; Hideho Tanaka

The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis

Jurgen Eckel, TANAKA Hideho, ISHII ShinichiLisen Liu, Hideho Tanaka

研究成果: Article

元の言語	English
ジャーナル	Default journal
出版物ステータス	Published - 1998 6 13

これを引用

Eckel, J., Hideho, TANAKA., Liu, ISHII. S., & Tanaka, H. (1998). The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis. Default journal.

@article{75d8953725b6409ca1b786672490dd8a,

title = "The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis",

author = "Jurgen Eckel and TANAKA Hideho and Liu, {ISHII ShinichiLisen} and Hideho Tanaka",

year = "1998",

month = jun,

day = "13",

language = "English",

journal = "Default journal",

}